BUSINESS REGISTRATION NUMBER
BRN 63859860
Live

RT Chinese Medicine Investment Limited

亞天丹道藥業投資有限公司

Registry Verified: 2020-10-08
Jurisdiction: Hong Kong, China

RT Chinese Medicine Investment Limited (亞天丹道藥業投資有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 2148205, and Business Registration Number (BRN) is 63859860. Incorporated on 2014-09-23, the entity has maintained continuous statutory operations for 12 years and 1 month, currently holding an active legal status of Live. The registered office is situated at ROOM 11, 10/F, KIN FAT INDUSTRIAL CENTRE, 13 KIN FAT STREET, TUEN MUN, NEW TERRITORIES, HONG KONG. Regarding statutory filings, pursuant to Section 662 of the Companies Ordinance (Cap. 622), its annual return filing window falls between Sep 23 – Nov 04 (within 42 days after its incorporation anniversary), with the latest Annual Return (Form NAR1) officially filed on 2020-10-08; a total of 10 statutory filings (spanning 2017–2020, latest filed on 2020-10-08) are indexed in the registry, comprising 4 Annual Return(s) (NAR1), 3 officer/secretary change notice(s) (ND2A), 2 registered office change(s) (NR1).

I. Corporate Profile & Statutory Registry Records

Official Chinese Name 亞天丹道藥業投資有限公司 Official English Name RT Chinese Medicine Investment Limited
Company Reg No. (CRN) 2148205 Business Reg No. (BRN)
63859860
Incorporation Date 2014-09-23 Company Category Private company limited by shares
Current Legal Status Live Statutory Filing Cycle
2026-09-23
Registered Office Address
ROOM 11, 10/F, KIN FAT INDUSTRIAL CENTRE, 13 KIN FAT STREET, TUEN MUN, NEW TERRITORIES, HONG KONGKin Fat Industrial Centre · View Co-Located Entities →
Significant Controllers (SCR) Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

II. Companies Registry Document Retrieval(Annual Return NAR1 & ND2A Filings)

#Filing DateDocument No.Document NamePagesTariffAction
12020-10-0870001894695
NAR1
Annual Return (2020)Latest Shareholders & Directors
12HK$ 28
22020-04-2370001738245
NR1
Notice of Change of Address of Registered Office
1HK$ 20
32020-01-2122902207028
NR1
Notice of Change of Address of Registered Office
1HK$ 20
42019-11-2522802026548
ND2A
Notice of Change of Company Secretary and Director
3HK$ 20
52019-10-1522802026547
NAR1
Annual Return (2019)
9HK$ 28
62018-09-2623301445889
NAR1
Annual Return (2018)
9HK$ 28
72017-09-2522701584215
NAR1
Annual Return (2017)
9HK$ 28
82017-09-2522701584217
ND2A
Notice of Change of Company Secretary and Director
3HK$ 20
92017-09-2522701584216
ND2B
Notice of Change of Company Secretary and Director (Particulars)
3HK$ 20
102017-04-1823201270646
AMEND
Amended Statutory Filing Document (English)
9HK$ 20

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.

IV. Corporate Statutory Dossier & Legal Status FAQ

Yes. RT Chinese Medicine Investment Limited is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2014-09-23 (operating for 12 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: October 2020).

The statutory primary identifiers for RT Chinese Medicine Investment Limited are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [63859860] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [2148205] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

Yes. Statutory indexing confirms that RT Chinese Medicine Investment Limited has accumulated 10 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2020-10-08: Form NAR1 - Annual Return (2020)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

The statutory registered office of RT Chinese Medicine Investment Limited on official record is situated at: [ROOM 11, 10/F, KIN FAT INDUSTRIAL CENTRE, 13 KIN FAT STREET, TUEN MUN, NEW TERRITORIES, HONG KONG]. Official registry dossiers also record 2 statutory registered office address change filing(s) (Form NR1). Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.

Retrieve Filings